Researchers from the University of Texas at Austin analysed 9,510 vaccination-related tweets from one week in January, 2012 to determine the most popular and influential messages.
A final sample of 2,580 tweets that had received engagement through re-posting and sharing was then coded for frequency of sharing, tone toward vaccinations, links to sources (eg, news outlets, advocacy groups, or healthcare providers), and whether the claims being made in each tweet were scientifically substantiated.
Overall, 33 per cent of the 2,580 tweets carried a positive tone about vaccines, 54 per cent were neutral, and 13 per cent were negative.
The most popular messages concerned a potential children's malaria vaccine, development of the NeuVax E-75 vaccine for breast cancer, the effectiveness of a herpes vaccine in women, the Centers for Disease Control and Prevention's recommendation of a human papilloma virus vaccination for boys, potential approval for a lung cancer vaccine, and a blog post discrediting vaccine-autism connections.
Frequent information sources shared through tweets included health-specific sites such as WebMD (16 per cent of 341 links), US media such as The New York Times (13 per cent), medical organisations such as the American Medical Association (12 per cent), and digital news aggregators including the Huffington Post (10 per cent).
"In this sample, it appears that Twitter users share mostly reputable information and sources while actively mobilising others to seek reliable health information," they said.
"Results of the snapshot can help explain what social media content patients consume and respond to, as well as help determine directions for educational campaigns," they said.
The study was published in the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
